news
Stay up to date with the most recent news on LeanMed & our efforts to improve the healthcare of the developing world
Open House Success!
Open House Success! Thank you to all those who attended our Open House event on March 7th. What a great evening it was showing off the new O2 Cube and connecting with friends, old and new! Big thank you to Deadalus for hosting the event and all the design and engineering work they put in over the…
O2 Cube Progression
New Vision, Same Mission Over the last 5 years, the LeanMed team has worked hard to engineer and develop an O2 Cube that could impact thousands of lives. Through customer discovery, market analysis, and in-country partnerships, we have now reached our first commercial product, the 10 LPM O2 Cube. While the vision for what the O2…
Innovation+Talks Podcast
Using lean startup for social impact with Mark Adkins Paul Heller, host of Innovation+Talks podcast, brings in LeanMed’s CEO and Co-Founder, Mark Adkins, to share his experience with lean startups, the affect pneumonia has in underserved regions, and how scaling products like the O2 Cube is complex but essential in making a social impact. Listen…
Press Release: LeanMed Welcomes New Team Roles to Expand Skillset
Press Release: LeanMed Welcomes New Team Roles to Expand Skillset Pittsburgh, PA – Today, LeanMed LLC, a medical technology company providing oxygen to patients in underdeveloped countries, announced the promotion of Jessica Starck to Chief Operating Officer and welcomed new team member, Jim Gilkison as their VP of Sales. Mark Adkins, CEO, recognizes this important…
Our Team Behind the Mission
Our Team Behind the Mission Since our inception in 2018, LeanMed has accomplished so much – from receiving recognition by the WHO and securing a licensing agreement with a major corporation as Philips, to initiating our first O2 Cube program in Nigeria to deliver life-saving oxygen to real patients – and we’re just getting started.…
Press Release: Goal Zero and LeanMed Collaborate to Bring Oxygen to Nigeria
Press Release: Goal Zero and LeanMed Collaborate to Bring Oxygen to Nigeria | Pittsburgh, PA – Today, Goal Zero announced the donation of the Yeti 3000X portable solar energy system to LeanMed for their Fast-Track Program, a rapid response program that will provide medical oxygen to rural health centers in Nigeria. This program is the…
Press Release: LeanMed LLC to Expand Access to Medical Oxygen Around the Globe Supported by Philips Technology
Press Release: LeanMed LLC to Expand Access to Medical Oxygen Around the Globe Supported by Philips Technology | Pittsburgh, PA – Today, LeanMed LLC announced a global non-exclusive licensing agreement with Philips, a global health technology leader, that will enable LeanMed to bring their solar powered oxygen production system, the O₂ Cube, to 40,000 rural…
Press Release: WHO Recognizes O2 Cube as Innovative Health Technology for Low Resource Settings
Press Release: WHO Recognizes O2 Cube as Innovative Health Technology for Low Resource Settings | Pittsburgh, PA – A new local startup, LeanMed, has secured the support of the World Health Organization (WHO) for their new solar powered oxygen production system, the O₂ Cube, in their 2021 Compendium of Innovative Health Technologies for Low-Resource Settings.…
World Pneumonia Day
World Pneumonia Day In these trying times, it is important to remember that COVID-19 is not the only devastating lower respiratory infection out there. Pneumonia is still a leading infectious cause of death, with over 2.5 million deaths every year. For this reason, even during this global pandemic, World Pneumonia Day will be held this…
Lean Med joins LifeX Labs
LeanMed Joins LifeX Labs We of Lean Med are proud to announce our entrance into the portfolio of LifeX Labs! LifeX Labs is a science startup accelerator focused on providing early stage companies with the support, resources, and ecosystem they need to be successful. Founded in 2018, LifeX Labs is a Pittsburgh accelerator that has…
Loading…
Something went wrong. Please refresh the page and/or try again.